Gastric Electrical Stimulators Market was valued at USD 1.5 Billion in 2022 and is projected to reach USD 2.8 Billion by 2030, growing at a CAGR of 8.5% from 2024 to 2030.
The gastric electrical stimulators GES market is gaining significant traction primarily due to increasing global rates of gastrointestinal disorders and the growing recognition of the therapeutic benefits of gastric pacing technology. This report presents a comprehensive analysis of the current market landscape and future outlook of the GES market considering its size growth drivers technological advancements and challenges in the coming years.
The global gastric electrical stimulators GES market is witnessing steady growth driven by rising incidences of obesity gastroparesis and other gastrointestinal conditions. As of the most recent market analysis the global market is valued at approximately USD 1.5 billion in 2024 and is expected to grow at a compound annual growth rate CAGR of around 7.5% over the next 5 10 years potentially reaching USD 2.9 billion by 2034.
The growth is largely attributed to an increase in lifestyle related diseases advancements in medical technology and the broadening scope of applications for GES. GES technology originally developed for the treatment of gastroparesis is now being explored for a variety of gastrointestinal and metabolic disorders including obesity and chronic acid reflux. Additionally with the rise in the aging population and a greater focus on minimally invasive treatments the market has been poised for a significant upward trajectory.
Key industry trends influencing market growth include advancements in implantable device technologies the increasing preference for non invasive or minimally invasive procedures and a greater shift towards personalized medicine which tailors treatments based on the individual’s medical needs.
Get an In-Depth Research Analysis of the Global Gastric Electrical Stimulators Market Size And Forecast [2025-2032]
Increasing prevalence of gastrointestinal disorders: The growing incidence of conditions such as gastroparesis obesity and functional dyspepsia has led to higher demand for effective treatments like GES. According to the National Institute of Diabetes and Digestive and Kidney Diseases NIDDK approximately 4 million people in the U.S. suffer from gastroparesis a condition where the stomach cannot empty properly.
Technological advancements: Significant improvements in gastric electrical stimulators have made them more effective safe and comfortable for patients. Developments in battery life miniaturization of devices and wireless communication features are enhancing their performance and usability.
Rising demand for minimally invasive procedures: As medical technology evolves there is a clear shift toward minimally invasive procedures with reduced recovery times and lower risks. GES devices which can be implanted via laparoscopic surgery are gaining popularity as a result.
High cost of treatment: The initial cost of implanting gastric electrical stimulators can be high and the cost of maintenance including battery replacements could be a barrier for patients especially in low income regions.
Regulatory hurdles: The regulatory approval process for GES devices can be complex and time consuming. In addition different regions may have varying regulations and standards leading to delayed market entry for some companies.
Limited awareness: Despite the growing recognition of GES as a treatment option for specific conditions there remains a lack of widespread awareness among both patients and healthcare providers about its potential benefits.
Expansion in emerging markets: With rising disposable incomes better healthcare infrastructure and increased healthcare awareness in emerging economies the GES market has significant growth opportunities in regions such as Asia Pacific and Latin America.
Product innovation: As the medical device industry is heavily reliant on innovation the development of advanced GES systems with improved features such as remote monitoring better patient compliance tracking and enhanced personalization offers substantial opportunities for companies.
Increase in obesity treatments: The growing global epidemic of obesity presents a major opportunity for the GES market especially since obesity is a key driver of many gastrointestinal issues that can be managed with gastric electrical stimulation.
The gastric electrical stimulators market can be segmented based on application end users and region. Each of these segments contributes differently to the overall market growth.
Gastroparesis: The largest application segment with GES devices frequently used to treat gastroparesis. GES helps to stimulate the stomach’s muscles aiding in better gastric emptying and reducing symptoms.
Obesity: As the obesity rate increases worldwide gastric electrical stimulators are emerging as a potential treatment for obesity. The devices help modulate gastric motility promoting satiety and reducing the risk of obesity related diseases.
Gastroesophageal Reflux Disease GERD: GES has been investigated as a potential therapy for GERD by enhancing esophageal motility and reducing acid reflux episodes improving patient quality of life.
Hospitals: The largest segment driven by the higher demand for specialized treatments in medical centers and hospitals. The adoption of GES in hospitals is encouraged due to the availability of expert care patient monitoring and necessary post operative care.
Ambulatory Surgical Centers ASCs: ASCs are gaining popularity due to their cost effectiveness minimal hospital stays and the growing trend of outpatient treatments.
Home Care Settings: With improvements in the technology of gastric electrical stimulators patients can now use the devices at home under medical supervision creating a growing market for home based care options.
North America: North America is currently the largest market for gastric electrical stimulators driven by advanced healthcare infrastructure a high prevalence of gastrointestinal disorders and robust research and development activities.
Europe: The European market is expected to grow significantly due to increased healthcare spending favorable reimbursement policies and rising awareness about GES as an alternative treatment.
Asia Pacific: Asia Pacific is anticipated to witness the highest growth rate due to improving healthcare systems rising disposable incomes and the increasing prevalence of obesity and diabetes in countries like China and India.
Latin America and Middle East & Africa: While these regions are expected to have slower growth the demand for gastric electrical stimulators is projected to increase due to expanding healthcare access and rising awareness of chronic health conditions.
The gastric electrical stimulators market is competitive with several key players leading the development and commercialization of GES technology. These include:
Medtronic: A pioneer in the medical device industry Medtronic is a leading player in the GES market offering the Enterra Therapy system which is used to treat gastroparesis. The company has a strong R&D presence and is constantly improving its GES products.
IntraPace: IntraPace’s Device the Transcend™ system is another notable competitor. It is specifically designed for the treatment of obesity and related disorders helping to reduce food intake and assist in weight management.
Boston Scientific: Boston Scientific is exploring gastric electrical stimulation for various applications including obesity and gastroparesis. Its commitment to innovation places it as a key player in the market.
Some emerging trends and innovations shaping the GES market include:
Personalized Gastric Stimulation: Advances in biometrics and patient monitoring have led to more customized treatment plans for individuals using gastric electrical stimulators. This trend is expected to enhance the effectiveness of GES particularly in obesity management.
Wireless Technologies: The integration of wireless technologies in GES devices enables remote monitoring and personalized adjustments improving treatment adherence and patient outcomes.
Miniaturization and Wearables: New designs aim to reduce the size of the devices making them more comfortable and easier to implant. Wearable versions of GES devices are also in development to offer more convenience and patient autonomy.
Despite the positive growth trajectory several challenges exist in the GES market:
High Cost of Devices and Procedures: The affordability of GES treatments remains a challenge particularly in low income countries. To address this manufacturers can work on reducing production costs through technological innovation and economies of scale.
Regulatory Delays: Navigating complex regulatory pathways can delay the time to market for new devices. Companies can expedite approval by collaborating closely with regulatory bodies and engaging in proactive clinical trials.
Patient Acceptance: Some patients may be hesitant to undergo implantation of GES
Medtronic
Reshape LifeSciences
IntraPace
Stanford Health Care
Metacure
Medtronic
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Gastric Electrical Stimulators Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Gastric Electrical Stimulators Market
Hospital
Outpatient Surgery Center
Based on Types the Market is categorized into Below types that held the largest Gastric Electrical Stimulators market share In 2023.
High Frequency Gastric Electrical Stimulator
Low Frequency Gastric Electrical Stimulator
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Gastric Electrical Stimulators Market Research Analysis
1. Introduction of the Global Gastric Electrical Stimulators Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Gastric Electrical Stimulators Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Gastric Electrical Stimulators Market, By Type
6. Global Gastric Electrical Stimulators Market, By Application
7. Global Gastric Electrical Stimulators Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Gastric Electrical Stimulators Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/